Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Tools-To-Sense

Financiado

Cerrado

A modular sensing and imaging toolkit for the early diagnosis of prostate cancer...

A modular sensing and imaging toolkit for the early diagnosis of prostate cancer employing lab on the chip methodologies This Proof-of-concept project will focus on the innovative exploitation of new diagnostic sensor prototypes which will tackle the early diagnosis of prostate cancer (PCa), one of the greatest concerns for ageing men worldwide. Th... ver más

30/04/2022

UBAH

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

UNIVERSITY OF BATH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-04-30

ERC-2020-POC: Call for proposals for ERC Proof of...

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

UBAH

150.00K€ | Lider

CENTORK VALVE CONTROL

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Nevada Diagnostics device for rapid testing of prostate cancer at P... 71K€ Cerrado

ProCanEx Prostate cancer diagnostic assay based on protein kinase act... 71K€ Cerrado

PROSTATOR Reliable urinary test for the diagnosis of prostate cancer 150K€ Cerrado

PROSENSE Cancer Diagnosis Parallel Sensing of Prostate Cancer Biomar... 4M€ Cerrado

OCProDx Strategic planning for commercialisation of a multiplexed pr... 71K€ Cerrado

PDC2021-121444-I00 BIOSENSOR PARA MONITORIZACION DE BIOMARCADORES DE CANCER COL... 86K€ Cerrado

Duración del proyecto: 18 meses Fecha Inicio: 2020-10-23
Fecha Fin: 2022-04-30

Líder del proyecto

UNIVERSITY OF BATH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 150K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto This Proof-of-concept project will focus on the innovative exploitation of new diagnostic sensor prototypes which will tackle the early diagnosis of prostate cancer (PCa), one of the greatest concerns for ageing men worldwide. The development of fast and reliable methods for detecting PCa by electrochemical or optical biosensing will address the unmet need for an early diagnosis and for monitoring non-invasively the PCa evolution post-diagnosis. Current PCa screening methods detect the prostate-specific antigen (PSA) by enzyme-linked immunosorbent assays (ELISA), but struggle to achieve detection limits below 1 ng/ml. This level of sensitivity is insufficient for the detection of circulating cancerous cells before symptoms of the disease appear: low levels of cellular cancer biomarkers such as PSMA (Prostate-specific membrane antigen) are present in blood up to 5 years before diagnosis. More accurate sensors interfaced with an actuator in sensing devices using lab-on-the-chip and applicable in ‘real-time’ will be devised hereby. The innovative prototypes of Tools-To-Sense will incorporate the chemical sensors already available through the underlining ERC Consolidator Grant O2Sense, which are tailored to target PCa cells for molecular imaging applications. These will be able to estimate the concentration of circulating PCa cells as the complex analyte under interrogation. We will focus on target identification and validation, bioassay development and quality control for early detection of PCa using nanotechnology. Biosensors incorporating peptides-functionalised graphene substrates will be assembled since field-effect transistors can achieve high sensitivity for the detection of a panel of PCa biomarkers. New biosensors incorporating dedicated molecular species that provide information about their chemical environment by generating a physical signal consisting of a combined electrochemical and fluorescence emission will be homologated by Tools-To-Sense.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores